Fate Therapeutics (FATE) PT Raised to $20 at BMO Capital; 'Enthusiasm for Cell Therapies Probably Justified'

March 6, 2018 1:13 AM

BMO Capital raised its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found